The Future of Scientific Evidence and Publications
Medical Affairs and publication teams face...
Friday, 6 Nov 2026
Biologics now represent around 40% of all pharmaceutical spending in Europe, and they’ve played a major role in transforming treatment outcomes in key disease areas such as cancer, autoimmune disorders, and diabetes. However, the complexity and cost of biologic development can challenge healthcare system sustainability, which can potentially delay timely and equitable access for patients.
Friday, 6 Nov 2026
Wednesday, 4 Nov 2026
Tuesday, 3 Nov 2026
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Reading this content is completely free
Already have an account? Sign in